Laboratory analysis demonstrates binding of monoclonal antibodies and nanobodies to LINE-1 ORF1p, suggesting potential utility for multicancer biomarker assays.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: